Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Why FDA approval of sickle cell gene therapy is a ‘big deal’

Season 2023 Episode 354 | 5m 08s

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.

Major corporate funding for the PBS News Hour is provided by BDO, BNSF, Consumer Cellular, American Cruise Lines, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Consumer Cellular and Cunard Cruise Line. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.
Extras
News Wrap: Russian drone and missile attack kills 10 in Ukraine
Missouri couple murdered in Guatemala after husband was deported
How shipping risks from Ukraine and Iran wars are converging
Breaking down the GDP report as U.S. economy slows in 2nd quarter
How music has helped tell America's story from the very beginning
Group urges Congress to adopt proportional representation to end redistricting battles
Blanche's AG nomination on hold over opposition to DOJ's 'anti-weaponization fund'
U.S. and Iran strikes intensify as war opens new fronts
Violence surges in West Bank as Israeli settlers escalate attacks on Palestinians
The campaign against Fauci and what brought him back before Congress